Postoperative Nausea and Vomiting in Laparoscopic Abdominal Surgery
Status:
Not yet recruiting
Trial end date:
2023-01-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare frequency with postoperative nausea and
vomiting in ASA( American Society of Anesthesiologists) I, II patients undergoing
laparoscopic surgery.
The main question[s] it aims to answer are:
- Primary Outcome is the incidence of nausea and vomiting between 0-6 and 6-24 hours
postoperatively and the need for additional antiemetics
- Secondary outcome is detection of additional analgesic needs and complications between
0-6 and 6-24 hours postoperatively.
Participants will receive aprepitant or granisetron for prevention of postoperative nausea
and vomiting.